申请人:Goldblum Adam A.
公开号:US20090036483A1
公开(公告)日:2009-02-05
The invention provides novel quinolinone-carboxamide 5-HT
4
receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT
4
receptor activity, and processes and intermediates useful for preparing such compounds.
该发明提供了新型的喹诺酮-羧酰胺5-HT4受体激动剂化合物。该发明还提供了包含这种化合物的药物组合物,使用这种化合物治疗与5-HT4受体活性相关的疾病的方法,以及用于制备这种化合物的过程和中间体。